Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Oct 1;13(5):894-897.
doi: 10.21037/hbsn-24-467. Epub 2024 Sep 26.

New insights on portal hypertension's screening in people with cystic fibrosis

Luigi Colecchia  1 , Federico Ravaioli  1 , Giovanni Marasco  1 , Elton Dajti  1   2 , Antonio Colecchia  3
Affiliations
Editorial

New insights on portal hypertension's screening in people with cystic fibrosis

Luigi Colecchia et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Porto-sinusoidal vascular disease (PSVD); cystic fibrosis; liver stiffness; portal hypertension; spleen stiffness.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-24-467/coif). G.M. reports payment or honoraria from AlfaSigma, AgPharma, Bromatech, Clorofilla, Echosense, Ferring, Giuliani, Mayoli Spindler and Schwabe Pharma; participation on a Data Safety Monitoring Board or Advisory Board of CINECA, EG Pharma, Monteresearch, Galenika, Recordati and has financial or non-financial interests with Noos and Menarini. A.C. reports payment or honoraria from Jazz Pharmaceuticals. The other authors have no conflicts of interest to declare.

Comment on

References

    1. Dana J, Debray D, Beaufrère A, et al. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies. J Hepatol 2022;76:420-34. 10.1016/j.jhep.2021.09.042 - DOI - PubMed
    1. Boëlle PY, Debray D, Guillot L, et al. Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients. Hepatology 2019;69:1648-56. 10.1002/hep.30148 - DOI - PMC - PubMed
    1. Debray D, Kelly D, Houwen R, et al. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros 2011;10 Suppl 2:S29-36. 10.1016/S1569-1993(11)60006-4 - DOI - PubMed
    1. Scott JA, Jones AM, Jokl E, et al. Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools. Heliyon 2023;9:e21861. 10.1016/j.heliyon.2023.e21861 - DOI - PMC - PubMed
    1. Scott J, Jones AM, Piper Hanley K, et al. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis. Aliment Pharmacol Ther 2022;55:389-400. 10.1111/apt.16749 - DOI - PubMed